Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Neueon Corporation Ltd

NEUEON
Trading

Neueon Corporation Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is already 96 weeks into its uptrend — timing risk, not thesis risk.

The price is in a confirmed uptrend (96 weeks in). Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.

Price
₹15.6
P/E
17.0×
of its own 0-year range
Revenue (Mar 26)
₹6.0 Cr
+20.0% YoY
Profit (Mar 26), incl. one-off
₹−206 Cr
one-off item — see below
Operating margin
−3,136.0%
−3,110.0 pp YoY
ROCE
−40%
FY26
ROIC
−44.2%
vs WACC 12.0% → −56.2 pp
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Neueon Corporation Ltd trades at ₹15.6, in a confirmed uptrend and 96 weeks into that stage. That is +90.5% against its own 200-day average. It sits at 55% of a 52-week range of ₹3 to ₹26. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).

Today the stock is in a confirmed uptrend — week 96 of stage 2, confirmed. At ₹15.6 it trades +90.5% versus its 200-day average and sits at 55% of its 52-week range (₹3–₹26).

Jul 26: ₹15.6 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 2-year window.
+90.5% versus the 200-day line, week 96 of stage 2
Price50-day avg200-day avg
S2₹28.0₹21.0₹14.1₹7.1₹0.0₹16₹8Mar 24Jul 24Nov 24Apr 26Jul 26
S2₹28.0₹21.0₹14.1₹7.1₹0.0₹16₹8Mar 24Nov 24Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (367 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Apr 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +38% while the NIFTY 500 moved +253% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-22) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Neueon Corporation Ltd trades at 17.0× P/E, against too little history to rank. Its long-run median P/E is 14.6×, measured across 0.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 17.0× is against too little history to rank, against a long-run median of 14.6× measured over 0.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 17.0× vs a 14.6× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 0.4-year window. The eps (ttm) bars are red where the reading is lower than the quarter before.
against too little history to rank
P/EMedianEPS (TTM) (quarterly)
17.6×₹0.716.2×₹0.514.9×₹0.413.5×₹0.212.1×₹0.0×17.00×₹1Apr 16May 16Jun 16Jul 16Sep 16
17.6×₹0.716.2×₹0.514.9×₹0.413.5×₹0.212.1×₹0.0×17.00×₹1Apr 16Jun 16Sep 16
P/E
17.0×
too little history to rank

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Neueon Corporation Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue +220.0% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
246%−298.8%153%−299.4%60%−300.0%−33%−300.6%−126%−301.2%%%220%−300%FY16FY21FY26
246%−298.8%153%−299.4%60%−300.0%−33%−300.6%−126%−301.2%%%220%−300%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
Revenue
224%137%50%−37%−124%%200%Jun 23Sep 24Mar 26
224%137%50%−37%−124%%200%Jun 23Sep 24Mar 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
−7.6%−16%−25%−34%−42%%−40%FY23FY24FY26
−7.6%−16%−25%−34%−42%%−40%FY23FY24FY26
ROCE
Falling
latest −40.0% · span −40.0%–−10.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+220.0%−36.4%
Share price+50.8%+3.3%
Revenue YoY (Mar 26)
+20.0%
latest quarter vs a year ago
Revenue 10y
−36.4%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

41.8/100 — rank 28 of 48 in Trading · 56% evidence confidence

Neueon Corporation Ltd scores 41.8 out of 100 against the 48 companies it is compared with in Trading, ranking 28. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 12.4 + 3.5 + 10 + 15.9 = 41.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Neueon Corporation Ltd reported ₹6.0 Cr of revenue in the Mar 26 quarter, +20.0% year on year. Over 10 years it has compounded at −36.4% a year. The last full year, FY26, came in at ₹16.0 Cr. The last four reported quarters add to ₹15.0 Cr.

FY26 revenue came in at ₹16.0 Cr (+220.0% on the year), capping 10 years at −36.4% compound. The latest quarter (Mar 26) printed ₹6.0 Cr, +20.0% year on year.

FY26 revenue ₹16.0 Cr (+220.0% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
−36.4% a year over 10 years
RevenueYoY growth
1.6k246%1.2k153%79260%396−33%0−126%₹ Cr%₹16220%FY16FY21FY26
1.6k246%1.2k153%79260%396−33%0−126%₹ Cr%₹16220%FY16FY21FY26
Mar 26: ₹6.0 Cr (+20.0% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
630%5−5.2%3−40%2−75%0−110%₹ Cr%₹620%Jun 23Sep 24Mar 26
630%5−5.2%3−40%2−75%0−110%₹ Cr%₹620%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +20.0% growth against the decade's −36.4% — the current year is running faster than its own long-run rate.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Neueon Corporation Ltd's operating margin is −3,136.0% in the Mar 26 quarter, −3,110.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −4,033.0% to 16.0%. The current quarter sits inside that band.

The latest quarter's operating margin is −3,136.0%, −3,110.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −4,033.0%–16.0%.

🚨 Why the margin moved: operating margin went −3,109.7 pp year on year while gross margin went +53.3 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: −1,222.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −4,033.0–16.0% band over 13 years
operating marginYoY change (pp)
340%2,325%−834%1,060%−2,009%−206%−3,183%−1,472%−4,357%−2,737%%%−1,222%−1,184%FY14FY20FY26
340%2,325%−834%1,060%−2,009%−206%−3,183%−1,472%−4,357%−2,737%%%−1,222%−1,184%FY14FY20FY26
Mar 26: −3,136.0% operating margin (−3,110.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
6,119%4,325%3,455%2,328%792%332%−1,871%−1,664%−4,535%−3,661%%%−3,136%−3,110%Jun 23Sep 24Mar 26
6,119%4,325%3,455%2,328%792%332%−1,871%−1,664%−4,535%−3,661%%%−3,136%−3,110%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Neueon Corporation Ltd posted a net loss of ₹206 Cr in the Mar 26 quarter. That quarter carries a one-off item larger than its own revenue, so the year-on-year figure is an artefact rather than a trading result. The full FY26 year was a loss of ₹326 Cr. That loss is 3,433.3% of the quarter's revenue.

Mar 26 profit was ₹−206 Cr, null year on year. On the full year, FY26 printed ₹−326 Cr (null).

🚨 Read this profit with care: at ₹−206 Cr it is larger than the whole quarter's revenue of ₹6.0 Cr — no operating business earns more than it sells, so this is a one-off item (a debt-to-equity conversion, a tax write-back or an asset sale), not money the business earned. The underlying operations are running at −3,136.0% operating margin; the year-on-year jump and any P/E built on this number are artefacts of the one-off, not a real earnings turn.

FY26 profit ₹−326 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
54−4,932.1%−142−4,932.7%−338−4,933.3%−533−4,933.9%−729−4,934.5%₹ Cr%₹−326−4,933.3%FY16FY21FY26
54−4,932.1%−142−4,932.7%−338−4,933.3%−533−4,933.9%−729−4,934.5%₹ Cr%₹−326−4,933.3%FY16FY21FY26
Mar 26: ₹−206 Cr (null YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
16−43−103−163−222₹ Cr₹−206Jun 23Sep 24Mar 26
16−43−103−163−222₹ Cr₹−206Jun 23Sep 24Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Neueon Corporation Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was ₹−38.0 Cr of operating cash against ₹−326 Cr of profit. After ₹−680 Cr of capital spending, ₹642 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY26: operating cash of ₹−38.0 Cr against reported profit of ₹−326 Cr, leaving free cash of ₹642 Cr after ₹−680 Cr of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹−38.0 Cr vs profit ₹−326 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY16 reflects an acquisition year — point shown clipped.
Operating cashNet profitFree cash
792249−293−835−1.4k₹ Cr₹−38₹−326₹642FY16FY21FY26
792249−293−835−1.4k₹ Cr₹−38₹−326₹642FY16FY21FY26
FY26: CFO = Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
of profit
100%
101.2%100.6%100.0%99.4%98.8%%FY16FY21FY26
101.2%100.6%100.0%99.4%98.8%%FY16FY21FY26

Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Neueon Corporation Ltd's cash conversion cycle runs 3,863 days in FY26, up from 2,365 days in FY17. Capital spending ran ₹−679 Cr over the last 3 years. At FY26 sales of ₹16.0 Cr each day of that cycle holds about ₹0.0 Cr, so roughly ₹169 Cr sits inside the business at any moment.

FY26: debtors at 3,863 days, inventory at 0 days — roughly 0.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 3,863 days, looser than FY17's 2,365.

In money terms: at FY26 sales of ₹16.0 Cr, each day of the cycle holds about ₹0.0 Cr — so the 3,863-day loop keeps roughly ₹169 Cr sitting inside the business at any moment.

FY26: a 3,863-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 9-year window.
+1,498 days vs FY17
Cash cycleInventory daysDebtor daysPayable days
42,63131,18419,7378,289−3,158days3,863d0d3,863d1,174dFY14FY16FY18FY20FY26
42,63131,18419,7378,289−3,158days3,863d0d3,863d1,174dFY14FY18FY26

On the investment side: capital spending of ₹−679 Cr over the last 3 fiscal years against ₹243 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹−680 Cr, work-in-progress ₹0.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
steady investment
CapexWork-in-progress
1.5k889313−263−839₹ Cr₹−680₹0FY16FY18FY21FY23FY26
1.5k889313−263−839₹ Cr₹−680₹0FY16FY21FY26

The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Neueon Corporation Ltd earns a ROCE of −40% in FY26. Return on invested capital clears the cost of that capital by −56.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −2,037.5% net margin on 0.06× asset turns.

FY26 ROCE is −40%.

🚨 Why the return is what it is — the wiring (FY26): −2,037.5% net margin × 0.06× asset turns × 1.20× balance-sheet leverage ≈ −146.7% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: −44.2% − 12.0% = a −56.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE −40% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the full ladder
ROCEROIC (annual)WACC
16%1.0%−14%−30%−45%%−40%−40.6%FY14FY20FY26
16%1.0%−14%−30%−45%%−40%−40.6%FY14FY20FY26
Q4 FY26: ROCE −115.9% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 9 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
22%−15%−52%−89%−126%%−115.9%5.5%Q4 FY21Q4 FY24Q4 FY26
22%−15%−52%−89%−126%%−115.9%5.5%Q4 FY21Q4 FY24Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Neueon Corporation Ltd carries total debt of ₹42.0 Cr against shareholder equity of ₹220 Cr as of Mar 26, a debt-to-equity of 0.19 — effectively unlevered. On the annual view that ratio went from −2.09 in FY21 to 0.19 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹42.0 Cr against shareholder equity of ₹220 Cr — a debt-to-equity of 0.19. On the annual view, debt-to-equity went from −2.09 (FY21) to 0.19 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹42.0 Cr at 0.19× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
2.7k0.4×2.0k−0.3×1.3k−0.9×668−1.6×0−2.3×₹ Cr×₹420.19×FY21FY24FY26
2.7k0.4×2.0k−0.3×1.3k−0.9×668−1.6×0−2.3×₹ Cr×₹420.19×FY21FY24FY26
Mar 26: debt ₹42.0 Cr, debt-to-equity 0.19 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
2.7k0.4×2.0k−0.3×1.3k−0.9×669−1.5×0−2.2×₹ Cr×₹420.19×Jun 21Mar 24Mar 26
2.7k0.4×2.0k−0.3×1.3k−0.9×669−1.5×0−2.2×₹ Cr×₹420.19×Jun 21Mar 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Promoters added 53.7 points of Neueon Corporation Ltd over 8 quarters, the biggest move on the register. That takes promoters to 90.0% of the company. Domestic institutions moved −0.7 points over the same window, to 0.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +53.7 points over 8 quarters to 90.0%; Domestic institutions: −0.7 points over 8 quarters to 0.2%.

Why the register moved: promoters drove it (+53.7 points), absorbed on the other side by domestic institutions (−0.7 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters +56.4 pts from Mar 21 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 4 year-ends held.
PromotersDomestic inst.Public
101%74%47%20%−7.3%%93.6%0.2%6.2%Mar 21Mar 24Mar 26
101%74%47%20%−7.3%%93.6%0.2%6.2%Mar 21Mar 24Mar 26
Promoters added 53.7 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersDomestic inst.Public
101%74%47%20%−7.3%%90%0.2%9.8%Mar 21Dec 24Jun 26
101%74%47%20%−7.3%%90%0.2%9.8%Mar 21Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Neueon Corporation Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Trading
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Rashi Peripherals LtdRPTECH 67.0/100Favorable setup71% evidence LEADER 21.1/35 Revenue 14.9% · PAT 34.8% · OPM change -0.1 pp 83% evidence 15.3/25 ROCE 16.8% · OPM 3% 76% evidence 10.8/20 P/E 19.8× · PEG — 15% evidence 19.8/20 RS sector 68.7% · RS bench 92.3% · 1Y 182.2%12 of 12 weeks ahead 100% evidence
Exact sum: 21.1 + 15.3 + 10.8 + 19.8 = 67 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Magnus Steel & Infra Ltd517320 66.9/100Thin evidence · provisional56% evidence 27.1/35 Revenue 100% · PAT 100% · OPM change 1.6 pp 83% evidence 18.6/25 ROCE 171% · OPM 21.3% 76% evidence 9.2/20 P/E 92.5× · PEG — 15% evidence 12.0/20 RS sector — · RS bench 46.1% · 1Y 1449.6%6 of 7 weeks ahead to 2026-06-28 25% evidence
Exact sum: 27.1 + 18.6 + 9.2 + 12 = 66.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Shankara Buildpro LtdBUILDPRO 63.2/100Thin evidence · provisional59% evidence TURNING 25.3/35 Revenue 28.8% · PAT 68.4% · OPM change 0.5 pp 88% evidence 17.3/25 ROCE 39% · OPM 3.5% 100% evidence 10.6/20 P/E 23.2× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence
Exact sum: 25.3 + 17.3 + 10.6 + 10 = 63.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Mangalam Global Enterprise LtdMGEL 63.0/100Mixed-positive evidence65% evidence TURNING 24.4/35 Revenue 41.4% · PAT 100% · OPM change 0.5 pp 95% evidence 16.6/25 ROCE 17% · OPM 1.9% 95% evidence 11.1/20 P/E 14.2× · PEG — 15% evidence 10.9/20 RS sector — · RS bench 10.1% · 1Y —3 of 3 weeks ahead 25% evidence
Exact sum: 24.4 + 16.6 + 11.1 + 10.9 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Vision Infra Equipment Solutions LtdVIESL 60.7/100Thin evidence · provisional51% evidence LEADER 18.8/35 Revenue — · PAT — · OPM change 2 pp 13% evidence 19.0/25 ROCE 19.6% · OPM 27% 95% evidence 10.5/20 P/E 25.1× · PEG — 15% evidence 12.4/20 RS sector 4.4% · RS bench 20.9% · 1Y 93.4%12 of 12 weeks ahead 100% evidence
Exact sum: 18.8 + 19 + 10.5 + 12.4 = 60.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
6Euro Pratik Sales LtdEUROPRATIK 60.5/100Mixed-positive evidence69% evidence TURNING 14.5/35 Revenue 18% · PAT 4% · OPM change 1 pp 88% evidence 21.1/25 ROCE 38.4% · OPM 27% 100% evidence 14.9/20 P/E 37.6× · PEG 0.62 65% evidence 10.0/20 RS sector — · RS bench — · 1Y —7 of 10 weeks ahead 0% evidence
Exact sum: 14.5 + 21.1 + 14.9 + 10 = 60.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
7Sudarshan Pharma Industries Ltd543828 59.8/100Mixed-positive evidence78% evidence LEADER 18.5/35 Revenue 38.9% · PAT 53.3% · OPM change -1 pp 83% evidence 14.3/25 ROCE 15.1% · OPM 9% 76% evidence 9.1/20 P/E 39.1× · PEG — 50% evidence 17.9/20 RS sector 9% · RS bench 27.5% · 1Y 45.7%12 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 14.3 + 9.1 + 17.9 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Lloyds Enterprises LtdLLOYDSENT 55.6/100Mixed-positive evidence71% evidence LEADER 21.4/35 Revenue 18.2% · PAT 100% · OPM change 1 pp 83% evidence 9.8/25 ROCE 3.7% · OPM 6% 76% evidence 8.7/20 P/E 1106× · PEG — 15% evidence 15.7/20 RS sector 4% · RS bench 22.5% · 1Y 10.6%12 of 12 weeks ahead 100% evidence
Exact sum: 21.4 + 9.8 + 8.7 + 15.7 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Tembo Global Industries LtdTEMBO 55.3/100Mixed-positive evidence70% evidence ASLEEP 20.0/35 Revenue 48.5% · PAT 78.2% · OPM change 1 pp 83% evidence 18.0/25 ROCE 22.8% · OPM 11% 95% evidence 11.3/20 P/E 11.2× · PEG — 15% evidence 6.0/20 RS sector -24.8% · RS bench -8.2% · 1Y 10.6%5 of 10 weeks ahead 70% evidence
Exact sum: 20 + 18 + 11.3 + 6 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Yogi Ltd511702 54.5/100Mixed-positive evidence61% evidence BREAKING OUT 24.2/35 Revenue 100% · PAT 100% · OPM change 3.6 pp 53% evidence 11.3/25 ROCE 12.8% · OPM 4.4% 76% evidence 10.0/20 P/E 36.4× · PEG — 15% evidence 9.0/20 RS sector -17.5% · RS bench -2.5% · 1Y -13.7%3 of 12 weeks ahead 100% evidence
Exact sum: 24.2 + 11.3 + 10 + 9 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Nupur Recyclers LtdNRL 53.8/100Mixed-positive evidence68% evidence TURNING 15.9/35 Revenue 36.4% · PAT 1.2% · OPM change 1.1 pp 83% evidence 16.1/25 ROCE 15.1% · OPM 6.4% 95% evidence 9.6/20 P/E 51.8× · PEG — 50% evidence 12.2/20 RS sector — · RS bench 60.1% · 1Y —2 of 2 weeks ahead 25% evidence
Exact sum: 15.9 + 16.1 + 9.6 + 12.2 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Arisinfra Solutions LtdARIS 53.5/100Thin evidence · provisional53% evidence ASLEEP 18.1/35 Revenue 39.1% · PAT 100% · OPM change 4.5 pp 62% evidence 15.3/25 ROCE 15.6% · OPM 9% 95% evidence 10.9/20 P/E 19.3× · PEG — 15% evidence 9.2/20 RS sector — · RS bench -2.4% · 1Y -11.4%4 of 10 weeks ahead 25% evidence
Exact sum: 18.1 + 15.3 + 10.9 + 9.2 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Aayush Art and Bullion Ltd540718 53.4/100Thin evidence · provisional54% evidence TURNING 20.9/35 Revenue 100% · PAT — · OPM change 1.6 pp 35% evidence 13.8/25 ROCE 18.9% · OPM 6% 76% evidence 9.0/20 P/E 233× · PEG — 15% evidence 9.7/20 RS sector -7.3% · RS bench 8.5% · 1Y 31.9%3 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 13.8 + 9 + 9.7 = 53.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Onix Solar Energy Ltd513119 52.1/100Mixed-positive evidence75% evidence ASLEEP 22.1/35 Revenue 100% · PAT 100% · OPM change 23 pp 95% evidence 11.3/25 ROCE 10% · OPM 30% 76% evidence 10.2/20 P/E 32.4× · PEG — 15% evidence 8.5/20 RS sector -8.1% · RS bench 29.6% · 1Y 32.1%3 of 12 weeks ahead 100% evidence
Exact sum: 22.1 + 11.3 + 10.2 + 8.5 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Bizotic Commercial Ltd543926 51.2/100Thin evidence · provisional58% evidence ASLEEP 19.7/35 Revenue — · PAT — · OPM change 0 pp 26% evidence 19.1/25 ROCE 26.8% · OPM 8% 76% evidence 10.4/20 P/E 29.6× · PEG — 50% evidence 2.0/20 RS sector -38% · RS bench -27.8% · 1Y 109.7%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 19.1 + 10.4 + 2 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
16Patel Retail LtdPATELRMART 51.2/100Thin evidence · provisional56% evidence TURNING 15.7/35 Revenue 27.7% · PAT 54.4% · OPM change -1.9 pp 83% evidence 14.6/25 ROCE 15.3% · OPM 5.2% 95% evidence 10.9/20 P/E 19.3× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —7 of 10 weeks ahead 0% evidence
Exact sum: 15.7 + 14.6 + 10.9 + 10 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
17Fabtech Technologies LtdFABTECH 51.2/100Thin evidence · provisional52% evidence ASLEEP 17.4/35 Revenue 14.2% · PAT 41% · OPM change 14.8 pp 71% evidence 12.7/25 ROCE 13.6% · OPM 5.7% 95% evidence 11.1/20 P/E 13.7× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 17.4 + 12.7 + 11.1 + 10 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18SG Mart LtdSGMART 50.2/100Mixed-positive evidence90% evidence LEADER 14.8/35 Revenue 10.4% · PAT 14.7% · OPM change 1.4 pp 95% evidence 9.2/25 ROCE 10.2% · OPM 4.5% 95% evidence 8.4/20 P/E 70.7× · PEG 1.92 65% evidence 17.8/20 RS sector 32.1% · RS bench 51.9% · 1Y 94.9%12 of 12 weeks ahead 100% evidence
Exact sum: 14.8 + 9.2 + 8.4 + 17.8 = 50.2 · Decision use: Price leads the evidence: RS versus the benchmark is 51.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
19Adani Enterprises LtdADANIENT 47.8/100Mixed-negative evidence93% evidence LEADER 14.6/35 Revenue 18.1% · PAT 4.2% · OPM change 0 pp 100% evidence 8.7/25 ROCE 5.8% · OPM 15% 100% evidence 7.7/20 P/E 172× · PEG 1.96 65% evidence 16.8/20 RS sector 5.5% · RS bench 23.2% · 1Y 21.7%12 of 12 weeks ahead 100% evidence
Exact sum: 14.6 + 8.7 + 7.7 + 16.8 = 47.8 · Decision use: Price leads the evidence: RS versus the benchmark is 23.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
20Shiv Aum Steels LtdSHIVAUM 47.8/100Thin evidence · provisional50% evidence 16.7/35 Revenue — · PAT — · OPM change 0.5 pp 32% evidence 11.5/25 ROCE 8% · OPM 3.8% 95% evidence 7.8/20 P/E 83.3× · PEG — 50% evidence 11.8/20 RS sector — · RS bench 35.4% · 1Y — 25% evidence
Exact sum: 16.7 + 11.5 + 7.8 + 11.8 = 47.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21BN Agrochem LtdBNAGROCHEM 47.1/100Mixed-negative evidence73% evidence TURNING 24.2/35 Revenue 100% · PAT 57.3% · OPM change 20.5 pp 88% evidence 7.0/25 ROCE 4.4% · OPM 1.6% 100% evidence 9.4/20 P/E 79.4× · PEG — 15% evidence 6.5/20 RS sector -19.2% · RS bench -10.6% · 1Y 3.2%8 of 8 weeks ahead 70% evidence
Exact sum: 24.2 + 7 + 9.4 + 6.5 = 47.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.2% and the one-year return is 3.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
22Hardwyn India LtdHARDWYN 46.2/100Mixed-negative evidence83% evidence ASLEEP 20.5/35 Revenue 8.3% · PAT 17.5% · OPM change 3.5 pp 83% evidence 12.3/25 ROCE 4.8% · OPM 10% 95% evidence 11.8/20 P/E 58.3× · PEG — 50% evidence 1.6/20 RS sector -45.2% · RS bench -15.3% · 1Y -21.1%4 of 12 weeks ahead 100% evidence
Exact sum: 20.5 + 12.3 + 11.8 + 1.6 = 46.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23MMTC LtdMMTC 45.3/100Mixed-negative evidence86% evidence ASLEEP 15.1/35 Revenue 0% · PAT 100% · OPM change -5633.5 pp 88% evidence 9.7/25 ROCE 8.7% · OPM — 84% evidence 13.8/20 P/E 94× · PEG 0.92 100% evidence 6.7/20 RS sector -22.9% · RS bench -3.3% · 1Y -6.7%7 of 11 weeks ahead 70% evidence
Exact sum: 15.1 + 9.7 + 13.8 + 6.7 = 45.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
24State Trading Corporation of India LtdSTCINDIA 44.8/100Thin evidence · provisional54% evidence TURNING 18.6/35 Revenue — · PAT 100% · OPM change -14.6 pp 43% evidence 7.5/25 ROCE -0.9% · OPM — 60% evidence 12.1/20 P/E 16.2× · PEG — 50% evidence 6.6/20 RS sector -30.7% · RS bench -1.9% · 1Y -6.2%5 of 11 weeks ahead 70% evidence
Exact sum: 18.6 + 7.5 + 12.1 + 6.6 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25PTC India LtdPTC 43.3/100Mixed-negative evidence78% evidence ASLEEP 13.2/35 Revenue 4.6% · PAT -26.5% · OPM change -1.3 pp 83% evidence 13.1/25 ROCE 13.4% · OPM 3.7% 76% evidence 10.6/20 P/E 8.5× · PEG — 50% evidence 6.4/20 RS sector -15.3% · RS bench -0.3% · 1Y -8.2%5 of 12 weeks ahead 100% evidence
Exact sum: 13.2 + 13.1 + 10.6 + 6.4 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26RRP Semiconductor LtdRRP 42.7/100Thin evidence · provisional51% evidence 12.2/35 Revenue -80% · PAT -80% · OPM change 3.3 pp 62% evidence 5.5/25 ROCE -32.7% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 15.0/20 RS sector 61.8% · RS bench 6.5% · 1Y 195.8%0 of 1 week ahead 70% evidence
Exact sum: 12.2 + 5.5 + 10 + 15 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27Riddhi Siddhi Gluco Biols Ltd524480 42.3/100Mixed-negative evidence78% evidence LEADER 12.1/35 Revenue 74.8% · PAT 0% · OPM change -77 pp 83% evidence 6.4/25 ROCE 2.7% · OPM -89% 76% evidence 7.0/20 P/E 26.4× · PEG — 50% evidence 16.8/20 RS sector 8.9% · RS bench 26.8% · 1Y 23.9%12 of 12 weeks ahead 100% evidence
Exact sum: 12.1 + 6.4 + 7 + 16.8 = 42.3 · Decision use: Price leads the evidence: RS versus the benchmark is 26.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
28Neueon Corporation Ltdthis pageNEUEON 41.8/100Thin evidence · provisional56% evidence ASLEEP 12.4/35 Revenue 100% · PAT -80% · OPM change -3110 pp 62% evidence 3.5/25 ROCE -40.4% · OPM — 80% evidence 10.0/20 P/E — · PEG — 0% evidence 15.9/20 RS sector 16.9% · RS bench 39.6% · 1Y —7 of 12 weeks ahead 70% evidence
Exact sum: 12.4 + 3.5 + 10 + 15.9 = 41.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Cropster Agro Ltd523105 41.0/100Mixed-negative evidence65% evidence 16.1/35 Revenue 28.4% · PAT 6.5% · OPM change 2.1 pp 83% evidence 11.8/25 ROCE 12.4% · OPM 8.7% 76% evidence 10.1/20 P/E 32.7× · PEG — 15% evidence 3.0/20 RS sector -73.5% · RS bench -60.9% · 1Y -70.2%0 of 4 weeks ahead 70% evidence
Exact sum: 16.1 + 11.8 + 10.1 + 3 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30Hexa Tradex LtdHEXATRADEX 37.9/100Mixed-negative evidence65% evidence ASLEEP 16.8/35 Revenue 0.4% · PAT 65% · OPM change 13.6 pp 62% evidence 4.2/25 ROCE -0.1% · OPM -191.7% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 6.9/20 RS sector -21.2% · RS bench -6.7% · 1Y -14.8%1 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 4.2 + 10 + 6.9 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
31Kothari Industrial Corporation LtdKOTIC 35.1/100Thin evidence · provisional59% evidence ASLEEP 19.8/35 Revenue 100% · PAT -80% · OPM change -1 pp 62% evidence 1.8/25 ROCE -28.9% · OPM -54% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 3.5/20 RS sector -60% · RS bench -45.5% · 1Y -60.3%0 of 7 weeks ahead 70% evidence
Exact sum: 19.8 + 1.8 + 10 + 3.5 = 35.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
32Shanti Overseas (India) LtdSHANTI 32.4/100Thin evidence · provisional56% evidence 11.3/35 Revenue -63.4% · PAT 100% · OPM change -200.5 pp 40% evidence 4.5/25 ROCE -25.2% · OPM -216.5% 71% evidence 13.3/20 P/E 3× · PEG — 50% evidence 3.3/20 RS sector -61.6% · RS bench -49.7% · 1Y -60.6%0 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 11.3 + 4.5 + 13.3 + 3.3 = 32.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
33Dhunseri Ventures LtdDVL 30.8/100Adverse evidence69% evidence ASLEEP 11.8/35 Revenue -30.8% · PAT -38.9% · OPM change -4 pp 62% evidence 6.0/25 ROCE 6.7% · OPM -85% 95% evidence 8.5/20 P/E 5.4× · PEG — 50% evidence 4.5/20 RS sector -45.9% · RS bench -14.2% · 1Y -33.4%2 of 10 weeks ahead 70% evidence
Exact sum: 11.8 + 6 + 8.5 + 4.5 = 30.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
34Uniphos Enterprises LtdUNIENTER 29.0/100Adverse evidence69% evidence ASLEEP 13.1/35 Revenue -71.3% · PAT 100% · OPM change -0.9 pp 62% evidence 3.0/25 ROCE 0.8% · OPM -3.1% 95% evidence 8.3/20 P/E 31.9× · PEG — 50% evidence 4.6/20 RS sector -45.2% · RS bench -25.4% · 1Y -41.1%1 of 10 weeks ahead 70% evidence
Exact sum: 13.1 + 3 + 8.3 + 4.6 = 29 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
35Oswal Agro Mills LtdOSWALAGRO 25.9/100Adverse evidence63% evidence ASLEEP 4.6/35 Revenue -80% · PAT -80% · OPM change -21782 pp 83% evidence 7.5/25 ROCE 2% · OPM — 80% evidence 10.0/20 P/E — · PEG — 0% evidence 3.8/20 RS sector -51.8% · RS bench -33.3% · 1Y -54.3%0 of 10 weeks ahead 70% evidence
Exact sum: 4.6 + 7.5 + 10 + 3.8 = 25.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
36Mardia Samyoung Capillary Tubes Company LtdMSCTC 57.2/100Thin evidence · provisional32% evidence 20.5/35 Revenue 100% · PAT 100% · OPM change — 29% evidence 15.7/25 ROCE 22.6% · OPM 15.3% 57% evidence 8.7/20 P/E 687× · PEG — 15% evidence 12.3/20 RS sector — · RS bench 74.6% · 1Y 236.1%6 of 12 weeks ahead to 2026-03-08 25% evidence
Exact sum: 20.5 + 15.7 + 8.7 + 12.3 = 57.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
37Proventus Agrocom LtdPROV 56.9/100Thin evidence · provisional48% evidence BREAKING OUT 19.5/35 Revenue — · PAT — · OPM change 0.2 pp 26% evidence 13.0/25 ROCE 11.5% · OPM 1.8% 95% evidence 13.1/20 P/E 39.6× · PEG — 50% evidence 11.3/20 RS sector — · RS bench 25.4% · 1Y —6 of 6 weeks ahead 25% evidence
Exact sum: 19.5 + 13 + 13.1 + 11.3 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
38SK Minerals & Additives Ltd544584 55.9/100Thin evidence · provisional31% evidence 16.2/35 Revenue — · PAT — · OPM change 0 pp 26% evidence 19.4/25 ROCE 26.2% · OPM 10% 76% evidence 10.3/20 P/E 30.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 16.2 + 19.4 + 10.3 + 10 = 55.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
39Monika Alcobev LtdMONIKA 54.6/100Thin evidence · provisional22% evidence 16.3/35 Revenue — · PAT — · OPM change -2 pp 15% evidence 17.6/25 ROCE 21% · OPM 15% 57% evidence 10.7/20 P/E 20.4× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -9%0 of 12 weeks ahead to 2026-03-08 0% evidence
Exact sum: 16.3 + 17.6 + 10.7 + 10 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
40Pramara Promotions LtdPRAMARA 53.1/100Thin evidence · provisional47% evidence 16.6/35 Revenue — · PAT — · OPM change -1 pp 15% evidence 14.3/25 ROCE 15.2% · OPM 15% 71% evidence 7.3/20 P/E 51.3× · PEG — 50% evidence 14.9/20 RS sector 7.6% · RS bench 29% · 1Y 72.6%10 of 12 weeks ahead to 2026-04-19 70% evidence
Exact sum: 16.6 + 14.3 + 7.3 + 14.9 = 53.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
41BMW Ventures LtdBMW 52.4/100Thin evidence · provisional26% evidence 17.9/35 Revenue — · PAT — · OPM change 0 pp 24% evidence 13.3/25 ROCE 13.6% · OPM 4% 57% evidence 11.2/20 P/E 13.4× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead to 2026-03-08 0% evidence
Exact sum: 17.9 + 13.3 + 11.2 + 10 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
42Manbro Industries Ltd512595 52.0/100Thin evidence · provisional22% evidence 18.3/35 Revenue — · PAT — · OPM change 32.8 pp 5% evidence 13.4/25 ROCE — · OPM 6.6% 23% evidence 10.0/20 P/E — · PEG — 0% evidence 10.3/20 RS sector -18.9% · RS bench 37.2% · 1Y 40.1%12 of 12 weeks ahead to 2026-05-03 70% evidence
Exact sum: 18.3 + 13.4 + 10 + 10.3 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
43Shah Foods Ltd519031 50.9/100Thin evidence · provisional17% evidence 17.3/35 Revenue — · PAT — · OPM change -10.7 pp 3% evidence 12.3/25 ROCE — · OPM -3.3% 30% evidence 8.9/20 P/E 293× · PEG — 15% evidence 12.4/20 RS sector — · RS bench 143.1% · 1Y — 25% evidence
Exact sum: 17.3 + 12.3 + 8.9 + 12.4 = 50.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
44Le Merite Exports LtdLEMERITE 48.2/100Thin evidence · provisional46% evidence 18.9/35 Revenue — · PAT — · OPM change 0.9 pp 15% evidence 9.3/25 ROCE 8.6% · OPM 2.8% 71% evidence 9.3/20 P/E 87× · PEG — 15% evidence 10.7/20 RS sector -10.6% · RS bench 15% · 1Y 42.1%1 of 1 week ahead to 2026-05-17 100% evidence
Exact sum: 18.9 + 9.3 + 9.3 + 10.7 = 48.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
45Keto Motors Ltd537392 46.8/100Thin evidence · provisional21% evidence 17.0/35 Revenue — · PAT -41.7% · OPM change — 12% evidence 7.3/25 ROCE -2.2% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 12.5/20 RS sector — · RS bench 378.2% · 1Y — 25% evidence
Exact sum: 17 + 7.3 + 10 + 12.5 = 46.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
46Satani Bearings Ltd505703 45.0/100Thin evidence · provisional37% evidence ASLEEP 20.1/35 Revenue — · PAT 100% · OPM change — 29% evidence 4.9/25 ROCE 1% · OPM 1.5% 76% evidence 8.5/20 P/E 11020× · PEG — 15% evidence 11.5/20 RS sector — · RS bench 28.3% · 1Y 153.4%0 of 10 weeks ahead 25% evidence
Exact sum: 20.1 + 4.9 + 8.5 + 11.5 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
47A-1 LtdA1L 41.5/100Thin evidence · provisional50% evidence 16.1/35 Revenue 8.3% · PAT -30.6% · OPM change -0.9 pp 53% evidence 11.1/25 ROCE 10.6% · OPM 2.9% 57% evidence 8.8/20 P/E 383× · PEG — 15% evidence 5.5/20 RS sector -26.6% · RS bench -16% · 1Y 26.3%6 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 16.1 + 11.1 + 8.8 + 5.5 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
48Blue Pearl Agriventures LtdBPAGRI 38.5/100Thin evidence · provisional50% evidence 17.1/35 Revenue 100% · PAT -46.7% · OPM change -2.5 pp 53% evidence 7.8/25 ROCE 2.6% · OPM 2.8% 57% evidence 8.6/20 P/E 5705× · PEG — 15% evidence 5.0/20 RS sector -35.6% · RS bench -25.1% · 1Y -37.5%1 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 17.1 + 7.8 + 8.6 + 5 = 38.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Neueon Corporation Ltd's share price today?

Neueon Corporation Ltd trades at ₹15.6. The company is valued at ₹883 Cr. The stock sits at 55% of its 52-week range of ₹3–₹26, +90.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 96 weeks in. — as of 31 July 2026.

What were Neueon Corporation Ltd's latest quarterly results?

Neueon Corporation Ltd reported revenue of ₹6.0 Cr and a net loss of ₹206 Cr for the Mar 26 quarter. Earnings per share were ₹−3.65. The operating margin was −3,136.0%, 3,110.0 pp lower than a year earlier. — as of 31 July 2026.

What is Neueon Corporation Ltd's revenue?

Neueon Corporation Ltd reported revenue of ₹6.0 Cr in the Mar 26 quarter, +20.0% year on year. For the full FY26 fiscal year, revenue was ₹16.0 Cr (+220.0%). Over the last 10 years revenue compounded at −36.4% a year. — as of 31 July 2026.

What is Neueon Corporation Ltd's profit?

Neueon Corporation Ltd earned ₹−206 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹−326 Cr. The operating margin ran −3,136.0% in the latest quarter. — as of 31 July 2026.

What is Neueon Corporation Ltd's market cap?

Neueon Corporation Ltd's market capitalisation is ₹883 Cr at a share price of ₹15.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

Does Neueon Corporation Ltd pay a dividend?

No — Neueon Corporation Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.

How is Neueon Corporation Ltd performing?

Neueon Corporation Ltd is in a confirmed uptrend, 96 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

Is Neueon Corporation Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 96 of stage 2), trading +90.5% versus its 200-day average and at 55% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Neueon Corporation Ltd beating the market?

Not lately — on a trailing-13-week view Neueon Corporation Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-06-22), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +38% against the NIFTY 500's +253% — behind the index over the full window. — as of 31 July 2026.

Will Neueon Corporation Ltd's share price go up?

This page publishes no price forecast for Neueon Corporation Ltd. What it measures instead: the share price is ₹15.6, the price is in a confirmed uptrend 96 weeks in. Direction is not something this site claims to know. — as of 31 July 2026.

Who owns Neueon Corporation Ltd?

Promoters hold 90.0% of Neueon Corporation Ltd, foreign institutions null%, domestic institutions 0.2% and the public 9.8% (latest quarter). The biggest move on the register over the last two years: Promoters added 53.7 points over 8 quarters. — as of 31 July 2026.

Does Neueon Corporation Ltd have too much debt?

No — Neueon Corporation Ltd's debt-to-equity is 0.19, and operating profit covers the interest bill −7×. FY26 borrowings were ₹42.0 Cr against equity of ₹221 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Neueon Corporation Ltd's capex?

Neueon Corporation Ltd spent ₹−679 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹−680 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Neueon Corporation Ltd's cash flow?

Neueon Corporation Ltd generated ₹−38.0 Cr of operating cash flow in FY26 and ₹642 Cr of free cash flow after ₹−680 Cr of capital spending. Reported profit that year was ₹−326 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Where is Neueon Corporation Ltd in its business cycle?

Neueon Corporation Ltd's FY26 operating margin was −1,222.0%, against a 13-year band of −4,033.0%–16.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −3,136.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Neueon Corporation Ltd story?

Biggest watch item: the price is already 96 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Neueon Corporation Ltd a stock worth studying right now?

This is not investment advice. The machine read: Neueon Corporation Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI